logo
Share SHARE
FONT-SIZE Plus   Neg

EARNINGS SUMMARY: Details of Nektar Therapeutics Q2 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$59.87 million in Q2 vs. -$48.60 million in the same period last year.
-EPS: -$0.39 in Q2 vs. -$0.36 in the same period last year.
-Analysts projected -$0.37 per share
-Revenue: $34.59 million in Q2 vs. $32.77 million in the same period last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

comments powered by Disqus
Follow RTT